Results 121 to 130 of about 15,184 (209)

The Dual-Ribozyme RNA Ladder and RNA-Calibrated ssDNA Marker System for Inexpensive RNA Size Standards. [PDF]

ACS Omega
Zhao Y, Lin J, Li M, Huang L, Xie Y, Wang J.   +5 more
europepmc   +1 more source

The Impact of Chronic Hepatitis D Virus Infection on Health-Related Quality of Life and Fatigue: A Real-World International Study. [PDF]

J Viral Hepat
Lampertico P, Gish RG, Reau N, Wedemeyer H, Buti M, Kaushik A, Yehoshua A, Burk C, Mirams L, Ellis H, Taylor-Whiteley T, Rock M.   +11 more
europepmc   +1 more source

HDV-Ak [PDF]

, 2019
openaire   +1 more source

An Exploratory Evaluation of the Present Prevalence of Hepatitis D Infection in Selected Populations from Venezuela, Contrasted with Past Studies in the Country. [PDF]

Microorganisms
Sulbarán MZ, Beltrán JA, Marín A, Lozano I, Mengual E, Castejón C, Cobis J, Lozano A, Comegna M, Perazzo R, De Sousa M, Martínez-Urbina N, Hidalgo M, Sulbarán YF, Aguilar M, Bravo M, Chemin I, Jaspe RC, Pujol FH.   +18 more
europepmc   +1 more source

Seroprevalence of hepatitis D among hepatitis B-infected patients attending the viral hepatitis treatment unit in Alexandria, Egypt: a prospective cross-sectional observational study. [PDF]

BMC Infect Dis
Elyamany A, Ghazala R, Aboud M, Kamal A.
europepmc   +1 more source

Absence of Detectable Anti-HDV Antibodies Among HBsAg-Positive Blood Donors, HIV-Infected Individuals and Patients With Chronic Hepatitis B in Sao Paulo, Brazil: Evaluation Using a Rapid Lateral Flow Assay. [PDF]

J Viral Hepat
Nishiya AS, Alencar CS, Gouvea MSG, Ono SK, Salles NA, Mendrone A, Gnouamozi GE, Nkongolo S, Urban S, Schinazi RF, Bassit L.   +10 more
europepmc   +1 more source

Anti-HDV [PDF]

, 2019
openaire   +1 more source

Management of chronic HBV-HDV patients chronic HBV-HDV infection

Hepatitis D virus was first described by Mario Rizzeto in 1977, and it is considered chronic viral hepatitis with the poorest prognosis. Despite its discovery almost 50 years ago, progress in its diagnosis and treatment has been scarce until recent years.
Buti, Maria||, Gonzalez, Alexia, Riveiro Barciela, Mar||, Bourliere, Marc   +3 more
openaire   +1 more source

MODERN TREATMENT OF HDV INFECTION

HDV infection frequently causes progression to cirrhosis and hepatocellular carcinoma (HCC). In summer 2020, the first potentially effective drug Bulevirtide (BLV) has been approved for the treatment of HDV by the EMA.
Rayimkulov R.G.
core  

Development and External Validation of an Algorithm for Identifying HDV RNA-Positive Patients. [PDF]

Gastro Hep Adv
Wong RJ, Gish RG, Jacobson IM, Lim JK, Debray T, McDonald S, Rock M, Leung G, Kim C.   +8 more
europepmc   +1 more source